The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor
Edits on 20 May, 2023
"Remove website redirecting to Patent Public Search front page"
US Patent 07297705 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsUS Patent 7297705 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands